PATENT CLAIM ANALYSIS

Application Number: 15885258
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["534", "558000"]

Abstract:
The disclosure provides compounds having formula (I): and the pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 2 ′, and X are as defined as set forth in the specification. Compounds having formula (I) are prodrugs that release glutamine analogs, e.g., 6-diazo-5-oxo-L-norleucine (DON). The disclosure also provides compounds having formula (I) for use in treating cancer.

Claim (Index 17):
A compound, or a pharmaceutically acceptable salt thereof, selected from the group consisting of:

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.68889
- Patent Class: 534.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15885147', '15502105', '15419642', '15318627', '11150500']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6890397330103716
- 35 USC 102 Novelty (BERT): 0.544193134542173
- Combined Prediction Score: 0.6745550731635517
- Mean Citation Score: 331.99464
- Max Citation Score: 421.0206
- Similarity Product: 304.153566773808

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test